| Authors: |
Oketch-Rabah HA; U.S. Pharmacopeial Convention, Rockville, MD, USA.; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Roe AL; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA.; Vice Chair, (USP GTEH EP, 2015-2020 cycle)., Rider CV; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Bonkovsky HL; U.S. FDA Liaison to the USP GTEH EP (2015-2020 cycle).; Section on Gastroenterology & Hepatology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Giancaspro GI; U.S. Pharmacopeial Convention, Rockville, MD, USA.; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Navarro V; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA.; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA., Paine MF; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA.; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA., Betz JM; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Marles RJ; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Casper S; U.S. FDA Liaison to the USP GTEH EP (2015-2020 cycle)., Gurley B; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Jordan SA; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., He K; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Kapoor MP; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Rao TP; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Sherker AH; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA.; Liver Diseases Research Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD, USA., Fontana RJ; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA.; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA., Rossi S; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA., Vuppalanchi R; U.S. FDA Liaison to the USP GTEH EP (2015-2020 cycle)., Seeff LB; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA., Stolz A; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA., Ahmad J; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA., Koh C; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA.; Liver Diseases Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, 10 Center Drive, Building 10, Rm 9B-16, Bethesda, MD, 20892,USA., Serrano J; Expert Members of the Drug Induced Liver Injury Network (DILIN), USA.; Liver Diseases Research Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD, USA., Low Dog T; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA., Ko R; United States Pharmacopeia Green Tea Hepatotoxicity Expert Panel (USP GTEH EP, 2015-2020 cycle), Rockville, MD, USA.; Chair (USP GTEH EP, 2015-2020 cycle). |
